Try searching for...

      Dr Eunice Dai
      /content/dam/genesiscare/headshots/au-doctor-headshots/AU_Oncology_Headshot_GA_Dr_Eunice_Dai.jpg
      Medical Oncologist

      Dr Eunice Dai

      Dr Eunice Dai
      Dr
      Eunice
      Dai

      MBBS (Hons), FRACP, BPharm

      For patients/carers

      For doctors

      MBBS (Hons), FRACP, BPharm

      Locations

      NSW:Campbelltown
      Campbelltown, NSW
      Campbelltown
      38 Camden Road, Campbelltown, NSW, 2560, Australia
      -34.071101399509224, 150.80602556751086
      /au/our-centres/nsw-campbelltown
      NSW

      Languages

      Fluent

      • English

      Biography

      Clinical interest in Oncology

      Dr Eunice Dai is an Australian medical oncologist with primary clinical interests in gastrointestinal and breast cancers.  She is a consultant medical oncologist practicing at Campbelltown Hospital.  

      Dr Dai undertook physician training at St Vincent’s Hospital in Sydney, and further advanced training in medical oncology at Liverpool, Campbelltown, and Bankstown Hospitals.  She went on complete a Phase 1 Clinical Trials research fellowship at Liverpool Hospital. 

      Dr Dai is committed to delivering empathetic, high quality, tailored patient care. She harbours a profound enthusiasm for translational research and clinical trials, recognising their pivotal role in offering patients innovative and individualised treatment pathways. Concurrent with her clinical practice, she is pursuing a PhD focused on predictive biomarkers in colorectal cancer patients receiving chemotherapy.  Dr Dai's research contributions extend globally and domestically, with notable co-authorship of Australian cardio-oncology guidelines. She engages in network multidisciplinary team discussions and places a strong emphasis on teaching, assessing, and guiding medical students and physician trainees in their professional development.

      More information

      Research interests

      Circulating tumour cells, circulating tumour DNA, and DNA damage response as predictive biomarkers in rectal cancer

      Professional memberships
      • COSA
      • MOGA
      • RACP